Viridian Therapeutics Reports Positive Phase 3 REVEAL-1 Data for Elegrobart in Thyroid Eye Disease

REVEAL-1 met the primary endpoint of Q4W proptosis responder rate (PRR) with a highly statistically significant treatment effect - - Elegrobart Q4W a...

March 31, 2026 | Tuesday | News
Biocytogen Signs Platform License Agreement with Taisho Pharmaceutical

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and develo...

March 31, 2026 | Tuesday | News
Nuclera Expands eProtein Discovery Platform with GPCR Nanodisc Panel

Enables expression of active GPCRs in 48 hours Panel supports screening to scale-up on eProtein Discovery Nuclera, the biotechnology comp...

March 31, 2026 | Tuesday | News
Mayo Clinic Secures $75 Million Grainger Family Gift to Power Next-Generation Healthcare Campus

Mayo Clinic announces a gift of $75 million from the Thomas and Elizabeth Grainger family to support Bold. Forward. Unbound. in Rochester, Mayo Clinic's ...

March 30, 2026 | Monday | News
Aragen Life Sciences Partners With Thermo Fisher Scientific To Strengthen Biologics Manufacturing Capabilities

Aragen Life Sciences, a leading contract research, development and manufacturing organisation, has announced the signing of a strategic Memorandum of Und...

March 26, 2026 | Thursday | News
Verana Health and Guardant Health Partner to Advance Real-World Clinicogenomic Data for Cancer Research

 Verana Health®, a digital health company dedicated to revolutionizing patient care and clinical research through real-world data (RWD), has ann...

March 26, 2026 | Thursday | News
Continuity Biosciences and Breakthrough T1D Partner to Advance NICHE® Cell Therapy Platform Toward First-in-Human Study

Continuity Biosciences and Breakthrough T1D, the leading global type 1 diabetes (T1D) advocacy organization, today announced a strategic collaboration to...

March 26, 2026 | Thursday | News
Boehringer Ingelheim Reports 7.3% Sales Growth in 2025, Advances Pipeline with Dual Breakthrough Launches

HERNEXEOS® (zongertinib) and JASCAYD® (nerandomilast) launched in H2, 2025 Group net sales increased 7.3%* to EUR 27.8 billion in 2025 R&...

March 26, 2026 | Thursday | News
SK pharmteco and Prozomix Partner to Accelerate Sustainable Biocatalysis in Small-Molecule Manufacturing

 SK pharmteco, a leading global contract development and manufacturing organization (CDMO), and Prozomix, a pioneer in enzyme discovery and diversity,...

March 26, 2026 | Thursday | News
Wilmington PharmaTech Invests $50M to Double U.S. API Manufacturing Capacity

Wilmington PharmaTech (“Wilmington”), a leading U.S.-based research, development, and manufacturing organization (CRDMO) focused on complex c...

March 25, 2026 | Wednesday | News
Gilead to Acquire Ouro Medicines in $2.17B Deal to Expand Autoimmune T Cell Engager Portfolio

Gilead Sciences, Inc. (Nasdaq: GILD) announced  it has entered into a definitive agreement to acquire Ouro Medicines, a privately held biotechnology...

March 25, 2026 | Wednesday | News
Biocytogen and Moonlight Bio Partner to Advance Next-Generation Cell Therapies for Hard-to-Treat Cancers

-Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and devel...

March 25, 2026 | Wednesday | News
Curi Bio, Battelle Join Forces to Accelerate Adoption of Human-Relevant NMJ Assays

Curi Bio, a world leader in human-relevant 3D tissue technology, and Battelle, the world’s largest independent nonprofit research and development o...

March 24, 2026 | Tuesday | News
New England Biolabs Launches EnClose Kit for Rapid Cell-Free dbDNA Synthesis

New England Biolabs announced the release of the EnClose Cell-free dbDNA Synthesis Kit, developed in collaboration with Touchlight. This novel kit enable...

March 23, 2026 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close